IP Library Assignment 068031/0059
Patent Assignment
Reel/Frame 068031/0059

Security Interest

Recorded: 2024-07-19 Received: 2024-07-19 Pages: 9
Assignor
ENDO OPERATIONS LIMITED
Executed: 2024-04-23
Assignee
GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
200 WEST STREET, 7TH FLOOR, ATTN: ANGELIQUE GAYLE IB OPS SYNDICATE, NEW YORK, NY, 10282, UNITED STATES
Covered Properties (29)
Oxytocin Compositions and Methods
Application: 63/616,999 →
Method of Assessing and Treating Cellulite
Application: 18/482,998 →
Isoproterenol Compositions and Methods
Application: 18/475,954 →
Sodium Bicarbonate Injectable Formulation and Methods Thereof
Application: 18/278,153 →
N-Acetylcysteine Compositions and Methods
Application: 18/359,685 →
Process Intermediate in the Purification of Collagenase Drug Substances
Application: 18/169,480 →
Hydralazine Compositions and Methods
Application: 18/146,756 →
N-Acetylcysteine Compositions and Methods
Application: 17/857,587 →
Method of Purifying and Isolating Collagenase
Application: 17/559,782 →
Method of Assessing and Treating Cellulite
Application: 17/461,481 →
Isoproterenol Compositions and Methods
Application: 17/179,078 →
N-Acetylcysteine Compositions and Methods
Application: 17/177,797 →
Phenylephrine Hydrochloride Compositions and Containers
Application: 17/154,516 →
Method of Producing Collagenase
Application: 15/939,231 →
Method of Assessing and Treating Cellulite
Application: 15/909,991 →
Solid Formulations of Liquid Biologically Active Agents
Application: 15/817,907 →
Misuse Preventative, Controlled Release Formulation
Application: 14/305,895 →
Misuse Preventative, Controlled Release Formulation
Application: 14/305,935 →
Misuse Preventative, Controlled Release Formulation
Application: 14/195,813 →
Misuse Preventative, Controlled Release Formulation
Application: 14/195,833 →
Misuse Preventative, Controlled Release Formulation
Application: 13/919,499 →
Misuse Preventative, Controlled Release Formulation
Application: 13/919,476 →
Misuse Preventative, Controlled Release Formulation
Application: 12/639,664 →
Misuse Preventative, Controlled Release Formulation
Application: 12/336,495 →
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
Application: 12/252,117 →
Ultrapure 4-Methylpyrazole
Application: 11/279,708 →
Sustained-Release Tramadol Formulations with 24-Hour Efficacy
Application: 11/112,008 →
Controlled-release compositions
Application: 11/111,996 →
Process for the Preparation of Amphiphilic Poly (N-Vinyl-2-Pyrrolidone) Block Copolymers
Application: 10/727,083 →